Skip to content

SABRA HEALTH CARE REIT, INC.: 10-Q filed 2013-08-05

What SABRA HEALTH CARE REIT, INC. reported in its quarterly report filed 2013-08-05 (fiscal Q2 2013): 22 published measures, 66 facts as tagged in accession 0001492298-13-000038.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-05
Fiscal period
fiscal Q2 2013
Accession
0001492298-13-000038 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SABRA HEALTH CARE REIT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-301,022,099,000USD
At 2012-12-31916,882,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-06-30596,532,000USD
At 2012-12-31611,394,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-30425,567,000USD
At 2012-12-31305,488,000USD
At 2012-06-30316,425,000USD
At 2010-12-31326,573,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-3092,770,000USD
At 2012-12-3117,101,000USD
At 2012-06-303,110,000USD
At 2011-12-3142,250,000USD
At 2010-12-3142,250,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-662,000USD91
2013-01-01 to 2013-06-308,895,000USD181
2012-04-01 to 2012-06-305,923,000USD91
2012-01-01 to 2012-06-3010,328,000USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-06-3022,986,000USD181
2012-01-01 to 2012-06-3024,087,000USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-04-01 to 2013-06-3032,275,000USD91
2013-01-01 to 2013-06-3064,297,000USD181
2012-04-01 to 2012-06-3025,117,000USD91
2012-01-01 to 2012-06-3048,844,000USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-06-3087,264,000USD181
2012-01-01 to 2012-06-3014,229,000USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-34,581,000USD181
2012-01-01 to 2012-06-30-77,456,000USD182

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-04-01 to 2013-06-3037,357,112shares91
2013-01-01 to 2013-06-3037,321,813shares181
2012-04-01 to 2012-06-3037,147,942shares91
2012-01-01 to 2012-06-3037,092,683shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-04-01 to 2013-06-3037,357,112shares91
2013-01-01 to 2013-06-3037,789,804shares181
2012-04-01 to 2012-06-3037,191,687shares91
2012-01-01 to 2012-06-3037,119,005shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-0.09USD/shares91
2013-01-01 to 2013-06-300.16USD/shares181
2012-04-01 to 2012-06-300.16USD/shares91
2012-01-01 to 2012-06-300.28USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-0.09USD/shares91
2013-01-01 to 2013-06-300.16USD/shares181
2012-04-01 to 2012-06-300.16USD/shares91
2012-01-01 to 2012-06-300.28USD/shares182

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-06-303,933,000USD181
2012-01-01 to 2012-06-303,842,000USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3037,333,943shares
At 2012-12-3137,099,209shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-30493,479,000USD
At 2012-12-31353,861,000USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2013-06-30554,379,000USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-06-3024,212,000USD
At 2012-12-3124,212,000USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-3,185,000USD91
2013-01-01 to 2013-06-306,068,000USD181
2012-04-01 to 2012-06-305,923,000USD91
2012-01-01 to 2012-06-3010,328,000USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-303,422,000USD91
2013-01-01 to 2013-06-308,139,000USD181
2012-04-01 to 2012-06-303,489,000USD91
2012-01-01 to 2012-06-307,810,000USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-04-01 to 2013-06-308,222,000USD91
2013-01-01 to 2013-06-3016,468,000USD181
2012-04-01 to 2012-06-307,557,000USD91
2012-01-01 to 2012-06-3014,860,000USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-2,851,000USD181
2012-01-01 to 2012-06-30144,000USD182

Inspect the source

Entity
SABRA HEALTH CARE REIT, INC. / CIK 0001492298
Captured
2026-09-20T09:10:10.598Z
SEC response SHA-256
e70eb840bd5aa8e83d03d1eb05aaccf39d18ee8d15b4193bfd620bd0c0f918d7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001492298.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))